Clinical management of women with metastatic breast cancer: a descriptive study according to age group.
about
Contemporary approaches for imaging skeletal metastasisThe lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cellsStabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicinHuman bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis.The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in SpainTreatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysisThe Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancerAge-related differences in persistence with bisphosphonates in women with metastatic breast cancer.Dystrophic Cutaneous Calcification and Metaplastic Bone Formation due to Long Term Bisphosphonate Use in Breast Cancer.Prognostic factors for patients with bone-only metastasis in breast cancerRole of sympathetic nerves in the establishment of metastatic breast cancer cells in boneRetrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastasesBone metastasis risk factors in breast cancer.Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: a 16-year retrospective review at the Douala general hospital, Cameroon.Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis.Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.Characterization of bone only metastasis patients with respect to tumor subtypes.Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data.Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.Prognostic factors for survival in metastatic breast cancer by hormone receptor status.TGF-α Overexpression in Breast Cancer Bone Metastasis and Primary Lesions and TGF-α Enhancement of Expression of Procancer Metastasis Cytokines in Bone Marrow Mesenchymal Stem Cells.Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.
P2860
Q26798170-84F46589-5142-4CCA-9AAD-DDEE73B443E7Q30439639-DE53A24C-D426-40C4-9704-8904AB1C2803Q33422353-194E8A1C-86BB-4FEB-ACBF-E8919D9D5C9FQ34473242-902ED3A7-3A23-47D5-B073-16D86C954267Q34561477-49878ED3-AE8C-4F54-8EA8-D156E7A333F8Q35584408-B088668D-B30B-45AC-A6B7-4630F8A2E0D4Q35686588-C42E38F7-9776-426C-B357-5C739A26DA12Q37005079-0C3BA5A6-E322-4E33-BAD0-8B1F5970365AQ37057757-8EDC8449-652D-487E-84D2-921CC6857D5BQ37094622-C573A4F7-0831-4618-AC93-31BD8773F2B8Q37337499-0D3D5714-D1C0-429D-8CEA-10A889B9B218Q37483543-6DAF0755-A13A-4846-A4CB-46B90C07DBF5Q37629662-D8BC7D0C-2721-4E49-ABEE-36DE5939807EQ37716195-17B6A8FA-F3B8-45E2-A8C6-922CF78AC6CCQ38324305-9B2A40D9-6487-4884-B313-9EB29CAFAFFCQ38581768-29EA6BA9-1994-4F4A-AD1C-C51D1EFC6BD1Q39579117-8B2D055D-0037-488F-82C0-AE4B27F7ECC7Q42453200-759D1508-B604-4430-AA71-0E087B0F269BQ47204396-0B124571-E44B-458A-B29D-641EFFF89421Q47547365-A6AFB3D1-2676-438F-9BDC-52831512AC1EQ47567895-1D28E2F0-6914-4729-9690-0564BD44A4D4Q49318816-8700FF28-36B2-4FEB-9547-081477DCB7D6Q52670810-F2200B8B-571C-40E6-B8E2-BE525FB3744DQ53130858-3FB58DCF-95C8-4FF2-8F1C-AECF7EB19575Q54356870-F9582D15-52DF-45E0-BDEB-D42F5730EE1DQ55039636-C2DD1292-FC53-4A84-8629-908897524B46Q55474543-B1F21E13-2C90-4C9C-8430-CFF96C5793EA
P2860
Clinical management of women with metastatic breast cancer: a descriptive study according to age group.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Clinical management of women w ...... study according to age group.
@ast
Clinical management of women w ...... study according to age group.
@en
type
label
Clinical management of women w ...... study according to age group.
@ast
Clinical management of women w ...... study according to age group.
@en
prefLabel
Clinical management of women w ...... study according to age group.
@ast
Clinical management of women w ...... study according to age group.
@en
P2093
P2860
P356
P1433
P1476
Clinical management of women w ...... e study according to age group
@en
P2093
Adri C Voogd
Geert-Jan Creemers
Gerard Vreugdenhil
Grard A P Nieuwenhuijzen
Klaartje Manders
Lonneke V van de Poll-Franse
Rudi M H Roumen
P2860
P2888
P356
10.1186/1471-2407-6-179
P407
P577
2006-07-06T00:00:00Z
P5875
P6179
1008040562